|
Market Closed -
Sao Paulo
15:43:07 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 9.230 BRL | +4.41% |
|
+25.92% | -55.84% |
| 10-19 | Ultragenyx Pharmaceutical Enters Settlement With Navinta Over Dojolvi | MT |
| 10-14 | Ultragenyx Pharmaceutical to Sell Priority Review Voucher for $203 Million | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.50% | +1.38% | +8.74% | +5.54% | +19.88% | +57.09% | +129.96% | +408.51% | +1,628.57% | 1,148B | |
| +0.86% | +5.14% | -0.33% | +1.62% | +30.97% | +45.00% | +86.15% | +66.44% | +135.01% | 652B | |
| -0.14% | +0.42% | +7.40% | +8.66% | +25.17% | +25.69% | +105.85% | +160.77% | +396.51% | 505B | |
| +0.71% | +2.30% | +14.83% | +10.89% | +22.21% | +54.03% | +66.22% | +13.29% | +76.31% | 384B | |
| -0.63% | -5.97% | -5.22% | +6.91% | +33.89% | +61.93% | +37.06% | +62.83% | +139.51% | 348B | |
| +3.30% | +3.51% | +10.32% | +2.82% | +21.72% | +35.43% | +57.63% | +76.36% | +89.49% | 294B | |
| +1.97% | +0.17% | +4.62% | -1.01% | -5.71% | +3.52% | +27.25% | +42.97% | +183.39% | 264B | |
| +0.87% | +3.08% | +8.06% | +14.94% | +38.04% | +54.69% | +72.74% | +118.10% | +211.22% | 244B | |
| +0.08% | +3.67% | +4.59% | +18.52% | +29.71% | +35.05% | +107.78% | +136.41% | +115.48% | 197B | |
| +1.28% | -2.61% | +2.46% | -23.72% | -20.72% | -23.00% | -61.95% | -26.78% | +112.75% | 168B | |
| -1.17% | -1.34% | +2.54% | +16.63% | +18.27% | +20.20% | -2.19% | -31.80% | -7.77% | 168B | |
| +1.66% | +0.99% | +0.38% | +8.01% | +16.84% | +25.40% | +49.09% | +191.04% | +582.77% | 134B | |
| -1.59% | -0.90% | -5.18% | -4.76% | +12.29% | +41.45% | +18.72% | +6.02% | +18.76% | 124B | |
| -0.67% | -5.41% | +12.18% | +7.99% | +17.10% | +19.39% | +114.40% | +368.52% | +673.96% | 112B | |
| -1.54% | -5.75% | -2.80% | -10.11% | -1.12% | +2.97% | +24.21% | -4.34% | -10.83% | 97.74B | |
| +1.09% | +1.81% | +6.77% | -4.52% | -7.75% | -13.21% | -9.31% | -11.71% | +7.54% | 101B | |
| +2.98% | -12.87% | +8.56% | +283.77% | +626.23% | +744.83% | +197.82% | -38.44% | - | 85.5B | |
| -0.35% | +0.94% | +8.11% | +16.99% | +5.36% | +24.26% | +4.91% | +30.08% | +128.56% | 81.21B | |
| +3.25% | +2.84% | +9.53% | +3.72% | +22.76% | +30.93% | +9.18% | -26.30% | +60.69% | 70.77B | |
| Average | +1.59% | -0.28% | +5.03% | +19.10% | +47.64% | +65.56% | +54.50% | +81.16% | +252.33% | 272.59B | |
| Weighted average by Cap. | +2.16% | +0.79% | +5.53% | +9.83% | +30.13% | +49.98% | +75.45% | +147.46% | +505.25% |
- Stock Market
- Stocks
- RARE Stock
- R2AR34 Stock
- Sector Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
